Wholesale of pharmaceutical and medical goods
DEEPX HEALTH AS
Revenue 2024
NOK 793,000
Operating profit
NOK −1.5m
Equity
NOK 141.3m
Incorporated
2002
Share capital
NOK 6.1m
Roles
Daglig lederChristian Horn
Regnskapsfører
Revisor
Styrets lederFilip Truyen
StyremedlemChristian Horn
StyremedlemHans Johan Hekland
Auditor
Audit firm
ERNST & YOUNG AS
ERNST & YOUNG AS har 238 registrerte statsautoriserte revisorer.
The Brønnøysund registers name the audit firm, not which individual auditor signs the accounts.
Shareholders
This list is shortened — open the ownership graph to see them all.
| Name | Stake | Shares | Year |
|---|---|---|---|
| PLASMACUTE AS | 26.6% | 20368187.000000 | 2025 |
| TJELTA AS | 16.6% | 12750000.000000 | 2025 |
| T.D. VEEN AS | 13.7% | 10501999.000000 | 2025 |
| MANALI AS | 10.2% | 7805155.000000 | 2025 |
| DEEPX HEALTH AS | 7.8% | 5947311.000000 | 2025 |
| CBLC HOLDING AS | 6.3% | 4804218.000000 | 2025 |
| SONGA INVESTMENTS AS | 2.6% | 2000000.000000 | 2025 |
| HANNIBAL INVEST AS | 2.3% | 1744141.000000 | 2025 |
| SCAN CHEMICALS AS | 1.4% | 1040000.000000 | 2025 |
| SKARABÉ AS | 1.3% | 1000000.000000 | 2025 |
| PIETER TRUYEN | 1.3% | 1000000.000000 | 2025 |
| XFILE AS | 1.2% | 900000.000000 | 2025 |
| CAM AS | 1.1% | 860000.000000 | 2025 |
| BARD INVEST AS | 1.0% | 730832.000000 | 2025 |
| HAADEM INVEST AS | 0.9% | 700000.000000 | 2025 |
| SYNESI AS | 0.8% | 600000.000000 | 2025 |
| METTE VALEUR | 0.7% | 503960.000000 | 2025 |
| TRIONFO AS | 0.6% | 430000.000000 | 2025 |
| GC RIEBER FORTUNA AS | 0.5% | 418333.000000 | 2025 |
| STAVANGER VENTURE AS | 0.5% | 369235.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| DEEPX ANALYTICS AS | Active | 100.0% | 1000.000000 |
| DEEPX HEALTH AS | Active | 7.8% | 5947311.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.